Rhabdomyosarcoma 2 Associated Transcript (RMST) as a Negative Regulator of Mammalian Target of Rapamycin (mTOR) in Cancer Cells

Text Registration

Rhabdomyosarcoma 2 Associated Transcript (RMST) as a Negative Regulator of Mammalian Target of Rapamycin (mTOR) in Cancer Cells

Status

Published

on 26 Mar 2020

Year of Creation

2019

Entkhab Alanisi

Registration Number

TX0008861216

on 26 Mar 2020

The U.S. Copyright record (Registration Number: TX0008861216) dated 26 Mar 2020, pertains to an electronic file (eService) titled "Rhabdomyosarcoma 2 Associated Transcript (RMST) as a Negative Regulator of Mammalian Target of Rapamycin (mTOR) in Cancer Cells" created in 2019. The copyright holder is Entkhab Alanisi, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Entkhab Alanisi.

Entkhab Alanisi

Application Details

Registration Number

TX0008861216

Registration Date

3/26/2020

Year of Creation

2019

Agency Marc Code

DLC-CO

Record Status

New

Physical Description

Electronic file (eService)

First Publication Nation

United States

Personal Authors

Entkhab Muhsen Abed Ali Alanisi

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Rhabdomyosarcoma 2 Associated Transcript (RMST) as a Negative Regulator of Mammalian Target of Rapamycin (mTOR) in Cancer Cells

Author Statement: Entkhab Muhsen Abed Ali Alanisi Citizenship: not known Authorship: text

Notes

Rights Note: Mark Dill, ProQuest, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600, disspub@proquest.com

Statements

Application Title Statement: Rhabdomyosarcoma 2 Associated Transcript (RMST) as a Negative Regulator of Mammalian Target of Rapamycin (mTOR) in Cancer Cells

Author Statement: Entkhab Muhsen Abed Ali Alanisi Citizenship: not known Authorship: text

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.